Back to the Corporate Site
Corporate Logo

Committee Charting

Email page
PDF view Print view Email Alert
Skip to content
Home | Contact Us  | Careers | Tenant Requests

Alexandria - Building the Future of Life Science logo

 
  • ABOUT ALEXANDRIA »
    • About Alexandria
    • Sustainability
    • Timeline
    • Meet Our Team
    • In The News
    • Careers
    • Contact Us
  • OUR CLUSTER MODEL »
    • Our Cluster Model
  • OUR LOCATIONS »
    • Our Cluster Locations
    • Greater Boston
    • San Francisco
    • New York City
    • San Diego
    • Seattle
    • Maryland
    • Research Triangle
  • OUR BUSINESS VERTICALS »
    • Real Estate
    • Corporate Responsibility
    • Venture Investments
    • Thought Leadership
  • FOR INVESTORS »
    • For Our Investors
      • Corporate Profile
      • Company Overview
      • Request Information
    • Financial Information
      • Stock Information
      • Analyst Coverage
      • SEC Filings
      • Dividends
      • Supplemental
      • Company Presentations
      • Annual Reports
      • Proxy
    • News, Events & Webcasts
      • Webcasts
      • Event Calendar
      • News
    • Corporate Governance
      • Disclosure
      • Insider Filings
      • Officers & Directors
      • Committee Charting
    • Email Notification
    • For Our Investors
      • Corporate Profile
      • Company Overview
      • Request Information
    • Financial Information
      • Stock Information
      • Analyst Coverage
      • SEC Filings
      • Dividends
      • Supplemental
      • Company Presentations
      • Annual Reports
      • Proxy
    • News, Events & Webcasts
      • Webcasts
      • Event Calendar
      • News
    • Corporate Governance
      • Disclosure
      • Insider Filings
      • Officers & Directors
      • Committee Charting
    • Email Notification
    • For Our Investors
      • Corporate Profile
      • Company Overview
      • Request Information
    • Financial Information
      • Stock Information
      • Analyst Coverage
      • SEC Filings
      • Dividends
      • Supplemental
      • Company Presentations
      • Annual Reports
      • Proxy
    • News, Events & Webcasts
      • Webcasts
      • Event Calendar
      • News
    • Corporate Governance
      • Disclosure
      • Insider Filings
      • Officers & Directors
      • Committee Charting
    • Email Notification
  • For Our Investors
    • Corporate Profile
    • Company Overview
    • Request Information
  • Financial Information
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Dividends
    • Supplemental
    • Company Presentations
    • Annual Reports
    • Proxy
  • News, Events & Webcasts
    • Webcasts
    • Event Calendar
    • News
  • Corporate Governance
    • Disclosure
    • Insider Filings
    • Officers & Directors
    • Committee Charting
  • Email Notification
  • For Our Investors
    • Corporate Profile
    • Company Overview
    • Request Information
  • Financial Information
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Dividends
    • Supplemental
    • Company Presentations
    • Annual Reports
    • Proxy
  • News, Events & Webcasts
    • Webcasts
    • Event Calendar
    • News
  • Corporate Governance
    • Disclosure
    • Insider Filings
    • Officers & Directors
    • Committee Charting
  • Email Notification
  • For Our Investors
    • Corporate Profile
    • Company Overview
    • Request Information
  • Financial Information
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Dividends
    • Supplemental
    • Company Presentations
    • Annual Reports
    • Proxy
  • News, Events & Webcasts
    • Webcasts
    • Event Calendar
    • News
  • Corporate Governance
    • Disclosure
    • Insider Filings
    • Officers & Directors
    • Committee Charting
  • Email Notification
IR Search

Contact Information

Alexandria Real Estate Equities, Inc.

26 N. Euclid Ave.
Pasadena, CA 91101


Investor Relations Contact

[email protected]
626.396.4828

Committee Charting

Committee Charting

  • By Committee
  • By Member
Joel S. Marcus Steven R. Hash John L. Atkins, III James P. Cain Maria C. Freire, PhD Jennifer Friel Goldstein Richard H. Klein James H. Richardson Michael A. Woronoff Charter Documents Charter Documents Charter Documents
Audit Committee $ $ CC $
Audit Committee Charter
Compensation Committee CC
Compensation Committee Charter
Nominating & Governance Committee CC
Nominating & Governance Committee Charter
Science & Technology Committee ECB CC
Audit Committee Compensation Committee Nominating & Governance Committee Science & Technology Committee
Joel S. Marcus ECB
Steven R. Hash $ CC
John L. Atkins, III CC
James P. Cain
Maria C. Freire, PhD CC
Jennifer Friel Goldstein
Richard H. Klein $ CC
James H. Richardson
Michael A. Woronoff $

Audit Committee

Committee Members
$ Steven R. Hash
$ CC Richard H. Klein
$ Michael A. Woronoff
Charter Documents
Audit Committee Charter

Compensation Committee

Committee Members
CC Steven R. Hash
John L. Atkins, III
Richard H. Klein
Charter Documents
Compensation Committee Charter

Nominating & Governance Committee

Committee Members
CC John L. Atkins, III
James P. Cain
Maria C. Freire, PhD
Charter Documents
Nominating & Governance Committee Charter

Science & Technology Committee

Committee Members
ECB Joel S. Marcus
James P. Cain
CC Maria C. Freire, PhD
Jennifer Friel Goldstein
James H. Richardson
Michael A. Woronoff

Joel S. Marcus

Joel S. Marcus
Joel S. Marcus is Executive Chairman and Founder of Alexandria Real Estate Equities, Inc. (NYSE:ARE), an urban office REIT that pioneered the life science real estate niche in 1994 and remains the longest-tenured owner, operator, and developer uniquely focused on collaborative life science, technology, and agtech campuses in AAA innovation cluster locations. Mr. Marcus co-founded Alexandria as a garage startup with $19 million in Series A capital and, as its Chief Executive Officer for 20 years from March 1997 to April 2018, led its growth into an S&P 500 company with a total market capitalization of over $18 billion and a total shareholder return of approximately 1,350% from the company’s May 1997 IPO to December 31, 2017. Alexandria reached its 20th anniversary as an NYSE listed REIT in May 2017. As of December 31, 2019, the company has a total market capitalization exceeding $26 billion and a total shareholder return of over 1,700%. Alexandria was named the NAIOP 2019 Developer of the Year and is a four-time Gold winner of the Nareit Investor CARE (Communications and Reporting Excellence) Award.

From first mover to leader in developing life science, technology, and agtech clusters, Alexandria has uniquely and successfully utilized Harvard Business Professor Michael Porter’s cluster theory as the foundation for its own proven cluster model, for which Alexandria identified four critical components for innovative companies to thrive: location, innovation, talent, and capital. To foster innovation and collaboration, Alexandria made the crucial decision to pursue its urban cluster campus strategy in Mission Bay (2004), New York City (2005), and Cambridge (2006). This strategic course, fueled by the company’s mission to create clusters that accelerate the world’s leading innovators in their pursuit of advancing human health by curing disease and improving nutrition, has helped shape Alexandria’s unique business model, which Mr. Marcus has built around four business verticals: real estate, venture investments, thought leadership, and corporate responsibility.

Mr. Marcus was named one of Real Estate Forum’s 2017 Best Bosses in commercial real estate and was previously a recipient of the EY Entrepreneur Of The Year Award (Los Angeles – Real Estate). Mr. Marcus earned his undergraduate and Juris Doctor degrees from the University of California, Los Angeles.
Committee Membership
ECB Science & Technology Committee

Steven R. Hash

Steven R. Hash
Steven R. Hash has served as a director since December 2013 and has served as Lead Director since March 2016. Mr. Hash is the President and Chief Operating Officer of Renaissance Macro Research, LLC, an equity research and trading firm focused on macro research in the investment strategy, economics, and Washington policy sectors, which he co-founded in 2012. Between 1993 and 2012, Mr. Hash held various leadership positions with Lehman Brothers (and its successor, Barclays Capital), including Global Head of Real Estate Investment Banking from 2006 to 2012, Chief Operating Officer of Global Investment Banking from 2008 to 2011, Director of Global Equity Research from 2003 to 2006, Director of U.S. Equity Research from 1999 to 2003, and Senior Equity Research Analyst from 1993 to 1999. From 1990 to 1993, Mr. Hash held various positions with Oppenheimer & Company’s Equity Research Department, including senior research analyst. He began his career in 1988 as an auditor for the accounting and consulting firm of Arthur Andersen & Co. He has served as a director of The Macerich Company (NYSE: MAC) since May 2015 (and is currently Non-Executive Chairman of the Board), as the lead director of Nuveen Global Cities REIT, Inc., a non-traded REIT, since January 2018, and as a Director of DiamondPeak Holdings Corp. since February 2019. Mr. Hash received a Bachelor of Arts degree in Business Administration from Loyola University and a Master of Business Administration degree from the Stern School of Business at New York University.
Committee Membership
$ Audit Committee
CC Compensation Committee

John L. Atkins, III

John L. Atkins, III
John L. Atkins, III, has served as a director since March 2007. Mr. Atkins, a licensed architect, is Chairman and Chief Executive Officer of O’Brien Atkins Associates, PA, a multidisciplinary design services firm that he co-founded in Research Triangle Park, North Carolina, in 1975. Mr. Atkins previously served as Chairman of the North Carolina Board of Architecture and was named an Emeritus Member of that board in 1988. Mr. Atkins was elevated in 1991 to the American Institute of Architects’ College of Fellows, an honor only 5% of architects receive. Mr. Atkins is immediate past Chairman of the North Carolina Biotechnology Center and currently serves as a Director and Executive Committee member. He is past Chairman of the North Carolina Railroad Company and is a director of the Kenan Institute for Engineering, Technology & Science, based at North Carolina State University. In 2005, Mr. Atkins was awarded the American Institute of Architects-North Carolina Chapter’s F. Carter Williams Gold Medal, the Chapter’s highest individual honor, in recognition of his distinguished career, and was named the 2005 College of Design’s Distinguished Alumnus by North Carolina State University. In 2003, Mr. Atkins also received the Watauga Medal, the highest nonacademic honor bestowed by North Carolina State University in honor of individuals who have made significant contributions to the university’s advancement. Mr. Atkins holds a Bachelor of Architecture degree from North Carolina State University and a Master of Regional Planning degree from the University of North Carolina at Chapel Hill.
Committee Membership
Compensation Committee
CC Nominating & Governance Committee

James P. Cain

James P. Cain
Ambassador James P. Cain has served as a director since December 2015. He is the Managing Partner of Cain Global Partners, LLC, a company that provides a vital link between the developed and emerging markets of the world by utilizing its network of diplomatic, political, and corporate resources. As a partner at Cain Global Partners, Ambassador Cain works with North American and European companies to expand their operations into international markets (such as Asia, Latin America, Eastern Europe, and the Middle East), as well as to support economic development and public policy interests. His career has spanned the fields of leadership, law, business, sports, and international diplomacy, and he has mastered the skills of building lasting relationships as well as strong ecosystems. Ambassador Cain’s unique combination of expertise and passion for business and leadership has been instrumental in his role in developing the Research Triangle Park innovation cluster. For 20 years, Ambassador Cain was a partner at the international law firm of Kilpatrick Townsend & Stockton LLP (formerly known as Kilpatrick Stockton), where he co-founded the firm’s Raleigh office in 1985. He continues to serve as counsel to Kilpatrick Townsend & Stockton. From 2000 to 2002, Ambassador Cain served as the President and Chief Operating Officer of the NHL Carolina Hurricanes and their parent company, Gale Force Holdings. Later, during his tenure as the U.S. Ambassador to Denmark, a position for which he was nominated by President George W. Bush on June 30, 2005 (to serve until January 2009), Ambassador Cain called upon not only his leadership and relationship-building skills, but also his experience from his time working with the Carolina Hurricanes. As Ambassador, he oversaw the 13 agencies of the American government that composed the U.S. Embassy in Copenhagen, where he focused his energies on areas of national security, counter-terrorism, energy security, commerce, and investment. He received his Bachelor of Arts and Juris Doctor degrees from Wake Forest University.
Committee Membership
Nominating & Governance Committee
Science & Technology Committee

Maria C. Freire, PhD

Maria C. Freire, PhD
Maria C. Freire, PhD has served as a director since April 2012. In November 2012, Dr. Freire became the President and Executive Director, and a member of the board of directors, of the FNIH, a Congressionally authorized independent organization that draws together the world’s foremost researchers and resources in support of the mission of the National Institutes of Health (NIH). Prior to her appointment to the FNIH, Dr. Freire was the President and a member of the board of directors of the Albert and Mary Lasker Foundation, a non-profit organization that bestows the Lasker Awards in basic and clinical science and advocates for medical research. From 2001 to 2008, Dr. Freire served as President and Chief Executive Officer of the Global Alliance for TB Drug Development, a public-private partnership that develops better, faster-acting, and affordable drugs to fight tuberculosis. An expert in technology commercialization, she directed the Office of Technology Transfer at the NIH from 1995 to 2001 and served as a commissioner on the World Health Organization’s Commission on Intellectual Property Rights, Innovation and Public Health.

Dr. Freire obtained her Bachelor of Science degree from the Universidad Peruana Cayetano Heredia in Lima, Peru, and her Ph.D. in Biophysics from the University of Virginia; she completed post-graduate work in Immunology and Virology at the University of Virginia and the University of Tennessee. She is currently a Director at Exelixis, Inc. (NASDAQ: EXEL) and has previously served on the Science Board of the Food and Drug Administration (FDA) and as a member of the Commission on a Global Health Risk Framework for the Future of the Institute of Medicine, among others.

Her awards include the Department of Health and Human Services Secretary’s Award for Distinguished Service, the Arthur S. Flemming Award, the Bayh-Dole Award, the 2017 Washington Business Journal's “Women Who Mean Business” Award, the 2017 Gold Stevie Award for “Woman of the Year,” and NonProfit PRO’s 2019 “Executive of the Year” Award. Dr. Freire is a member of the U.S. National Academy of Medicine and the Council on Foreign Relations
Committee Membership
Nominating & Governance Committee
CC Science & Technology Committee

Jennifer Friel Goldstein

Jennifer Friel Goldstein
Jennifer Friel Goldstein has served as a director since March 26, 2020. She has 20 years of investing, banking, business development, portfolio management, and strategy experience, as well as a biotechnology background. Since November 2012, Ms. Goldstein held several positions with Silicon Valley Bank (SVB) and currently serves as the Head of Business Development, Technology and Healthcare, where she is responsible for business development, venture capital relationship management, and corporate relationship management across all sectors for the bank. From July 2006 to September 2012, Ms. Goldstein served on Pfizer Inc.’s Venture Capital team, during which time she helped lead or co-lead fund-of-fund investment decisions and manage Pfizer's private equity portfolio. Ms. Goldstein has also served as a consultant at Bain & Company in London, where she focused on private equity transactions across Europe. Additional experience at companies such as Chiron, Genelabs, and Genencor further developed Ms. Goldstein’s diverse operational and research skills. Ms. Goldstein also serves on the board of the Leukemia & Lymphoma Society in Silicon Valley. Ms. Goldstein graduated magna cum laude with a Bachelor of Science in Engineering degree in Bioengineering and a Master of Biotechnology degree from the University of Pennsylvania. Ms. Goldstein was also named a Joseph Wharton Fellow while completing her Master of Business Administration degree at the Wharton School.
Committee Membership
Science & Technology Committee

Richard H. Klein

Richard H. Klein
Richard H. Klein has served as a director since December 2003. Mr. Klein has a diverse background spanning more than 30 years as a senior advisor to a variety of domestic and international businesses, with a particular focus on real estate organizations. He currently serves as Chief Financial Officer of Industrial Realty Group, LLC, a privately-held owner and developer of commercial and industrial properties with a 110 million square foot portfolio located throughout the United States. From 2012 to 2015, Mr. Klein served as an independent business consultant. In 2003, Mr. Klein founded Chefmakers Cooking Academy LLC, which provided culinary education services and experiences and for which he served as Chief Executive Officer through 2011. From 1984 to 2000, Mr. Klein was with Ernst & Young LLP, and a predecessor firm, Kenneth Leventhal & Company. From 1978 to 1983, Mr. Klein provided tax consulting and auditing services for PricewaterhouseCoopers LLP. At these firms, Mr. Klein served in a variety of capacities, including as partner in the REIT Advisory Practice, the Financial Restructuring and Insolvency Practice, and the Public Relations and Practice Development Department. Mr. Klein is a certified public accountant in the State of California. He received his Bachelor of Science degree in Accounting and Finance from the University of Southern California.
Committee Membership
$ CC Audit Committee
Compensation Committee

James H. Richardson

James H. Richardson
James H. Richardson has served the Company as a senior management consultant since February 2009. Mr. Richardson previously served the Company as President from August 1998 to February 2009, as a director since March 1999, and in other capacities from August 1997 to August 1998. Prior to joining the Company, Mr. Richardson held management and brokerage positions for nearly 15 years at CB Richard Ellis, Inc., a full-service provider of commercial real estate services. He was a top producer within the brokerage services group as well as a senior leader responsible for strategy and operations. During his time at CB Richard Ellis, Inc., Mr. Richardson was instrumental in the creation and development of the biosciences and corporate services practice groups. Mr. Richardson received his Bachelor of Arts degree in Economics from Claremont McKenna College.
Committee Membership
Science & Technology Committee

Michael A. Woronoff

Michael A. Woronoff
Michael A. Woronoff has served as a director since July 2017. Mr. Woronoff is currently a Partner at Kirkland & Ellis LLP (K&E). He advises clients on a variety of corporate and securities law matters, including SEC reporting obligations, corporate governance, and strategic alliances. Prior to joining K&E in 2019, he was a partner at Proskauer Rose LLP (“Proskauer”), head of Proskauer’s Los Angeles office, co-head of its international PEMA group, and a member of the firm’s Executive Committee. Prior to joining Proskauer in 2004, Mr. Woronoff co-founded and was a principal of Shelter Capital Partners (Shelter), a Southern California-based private equity fund that invested in technology and technology-enabled businesses at all stages of development. Prior to joining Shelter in 2000, Mr. Woronoff was a partner of Skadden, Arps, Slate, Meagher & Flom LLP (Skadden), where he practiced corporate and securities law for 15 years. He received a Juris Doctor degree from the University of Michigan Law School, a Master of Science in Industrial Administration degree from Krannert Graduate School of Management at Purdue University, and a Bachelor of Science in Industrial Management degree from Purdue University.
Committee Membership
$ Audit Committee
Science & Technology Committee
$= Financial Expert
CC= Chairperson
ECB= Executive Chairman
= Member
*To view the charter documents for the Audit, Compensation, and Nominating & Governance Committees, click on the committee name at the top of the table.
Email page
PDF view Print view Email Alert
Copyright 2020, © S&P Global Market Intelligence  Terms of Use

TERMS AND CONDITIONS OF USE

PDF View Print View

The investor relations site ("Site") with which this document is associated is maintained by S&P Global Market Intelligence ("S&P") on behalf of the organization featured on the Site (S&P's "Client"). These Terms and Conditions of Use ("Terms of Use") set forth the terms on which you may use the Site, and the information and materials contained therein (the "Contents"). By using the Site, you agree to these Terms of Use. If you do not agree to these Terms of Use, you are not authorized to use the Site or Contents in any manner, and you should immediately discontinue any use of the Site or the Contents.

S&P and/or its Client shall have the right at any time to modify or discontinue any aspect of the Site or any part of the Contents. S&P may also modify these Terms of Use without notice. You agree to monitor these Terms of Use, and to cease all access or use of the Site if you no longer agree to abide by the Terms of Use. Your continued use of the Site shall constitute acceptance of such modification.

S&P and the Client grant to you a limited, personal license to access the Site and to access and download the Contents, but only for your own personal, family and household use. You may not use, reproduce, distribute or display any portion of the Site for any other purpose, including without limit any commercial purpose. You may use the Site and the Contents for lawful purposes only. S&P and Client reserve all rights not expressly granted, including the right to terminate your use of the Site without notice.

The Site contains copyrighted material, trademarks and service marks, and other proprietary information, including but not limited to text, software, and graphics, which materials are owned by S&P and/or its Client. S&P and Client reserve all rights in the Contents. You agree not to reproduce, distribute, sell, broadcast, publish, retransmit, disseminate, circulate or commercially exploit the Site or the Contents without the express written consent of S&P and the Client.

You agree to access the Contents and the Site manually, by request, and not automatically, through the use of a program, or other means. You agree not to take any action, alone or with others, that would interfere with the operation of the Site, to alter the Site in any way, or to impede others' access to and freedom to enjoy and use the Site as made available by S&P and S&P’s Client.

THE SITE AND THE CONTENTS ARE PROVIDED ON AN "AS IS" BASIS. S&P, ITS CLIENT, AND ANY OTHER PROVIDERS OF THE INFORMATION EXPRESSLY DISCLAIM ALL WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY WARRANTY OF ACCURACY, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT.

NEITHER, S&P, THE CLIENT NOR EITHER OF THEIR AFFILIATES, SHAREHOLDERS, OFFICERS, EMPLOYEES, AGENTS OR REPRESENTATIVES SHALL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, EXEMPLARY , PUNITIVE SPECIAL OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR RELATING TO THE SITE, THE USE OF OR INABILITY TO USE THE SITE, OR THE CONTENTS, EVEN IF SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. IN PARTICULAR, S&P WILL NOT BE LIABLE FOR ANY LOSS OR DAMAGE CAUSED BY YOUR RELIANCE ON INFORMATION OBTAINED THROUGH THE SITE.

It is your responsibility to evaluate the accuracy, completeness or usefulness of any of the Contents available on the Site. Please seek the advice of professionals regarding the evaluation of any of the information on the Site.

The Site does not represent an offer or solicitation with respect to the purchase or sale of any security.

These Terms of Use are the entire agreement between the parties with respect to its subject matter, and it can be amended only via written agreement by S&P. These terms and conditions shall be governed by the law of New York, without regard to principals of conflicts or choice of laws.
 

© 2020 Alexandria Real Estate Equities, Inc.

Terms of Use | Privacy